- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Infectious Disease Therapeutics Market is expected to reach US$ 1,67,883.93 million by 2030
Jan 25, 2024
FDA Clears ACCRUFeR® (ferric maltol) for Iron Deficiency
Feb 18, 2026
AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate
Jul 15, 2020
Sickle Cell Disease Treatment Market is expected to reach US$ 4,691.87 million by 2030
Nov 07, 2023
Small Cell Lung Cancer (SCLC) Treatment Market is expected to reach US$ 9,173.60 million by 2030
Dec 21, 2023
Osteonecrosis Treatment Market is expected to reach US$ 1,021.92 million by 2030
Dec 12, 2023
Pharmaceutical Contract Sales Organizations Market is expected to reach US$ 15,820.86 million by 2030
Oct 11, 2023
Follow us on
